HCPCS Level II

J9359

Injection, loncastuximab tesirine-lpyl, 0.075 mg

Ask Rivvi

79952-0110-01 Zynlonta, ADC Therapeutics America, Inc.. Billable units per 11-digit NDC: 134.

Source: CMS ASP NDC-HCPCS crosswalk, effective October 1, 2026 through December 31, 2026.

Free to start. Most teams are using it the same day.